Tech Company Financing Transactions
Tetra Pharm Technologies Funding Round
On 1/26/2023, Tetra Pharm Technologies landed $9.8 million in Series A funding from Enexis, Leafy Tunnel and Nesroht Holding.
Transaction Overview
Company Name
Announced On
1/26/2023
Transaction Type
Venture Equity
Amount
$9,790,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to increase its capacity in research and development and expand its commercial operations internationally.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Søndre Jernbanevej 11
Hillerod, 3400
DK
Hillerod, 3400
DK
Phone
Undisclosed
Website
Email Address
Overview
Tetra Pharm is committed to investigate new drug candidates, design and develop new drug formulations, conduct clinical trials, and commercialise medicines targeting the endocannabinoid system. With a location in Medicon Valley, one of the leading life-science clusters in Europe, Tetra Pharm is privileged to be part of an environment that occupies some of the best scientists within biotechnology and pharmaceutical manufacturing in the World.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Martin Rose
Co-Founder
Jesper Breum
Browse more venture capital transactions:
Prev: 1/26/2023: Kittl venture capital transaction
Next: 1/26/2023: PortPro venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs